NF-κB pro-survival function is also critical in inflammation-driven tumor progression, as demonstrated in syngeneic colon and breast cancer xenograft models, where inflammation-associated NF-κB activation mediates tumor growth by conferring resistance to TRAIL death cytokine28. Here, NFKB1 is linked to neoplasm.